CLPT

SEC source: 0001285550-23-000027 · wf-form4_167831225156484.xml · derivative · entry 2

SABRA MAZIN · CIK 0001947604 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,567

Underlying: Common Stock · 34,567 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

F3 · derivative.exercise_date: The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

SEC source: 0001285550-23-000027 · wf-form4_167831225156484.xml · derivative · entry 1

SABRA MAZIN · CIK 0001947604 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,522

Underlying: Common Stock · 11,522 shares

Expires 2033-03-06

F1 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

SEC source: 0001285550-23-000016 · wf-form4_167718836083205.xml · nonDerivative · entry 1

STIGALL L. JEREMY · CIK 0001929859 · GM, Biologics & Drug Delivery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,906

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001285550-23-000008 · wf-form4_167287314329964.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,038

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $7.97 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending December 30, 2022.

SEC source: 0001285550-23-000006 · wf-form4_167287309071574.xml · nonDerivative · entry 1

FLETCHER R JOHN · CIK 0001215024 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,461

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $7.97 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending December 30, 2022.

SEC source: 0001285550-23-000007 · wf-form4_167287312360999.xml · nonDerivative · entry 1

Girin Pascal E R · CIK 0001329811 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,653

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $7.97 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending December 30, 2022.

SEC source: 0001285550-23-000005 · wf-form4_167287306641198.xml · nonDerivative · entry 1

JOHNSON B KRISTINE · CIK 0001231984 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,453

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $7.97 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending December 30, 2022.

SEC source: 0001285550-23-000014 · wf-form5_167510546534801.xml · nonDerivative · entry 1

STIGALL L. JEREMY · CIK 0001929859 · GM, Biologics & Drug Delivery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,420

F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2022 through December 30, 2022. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.

SEC source: 0001285550-23-000013 · wf-form5_167510544522847.xml · nonDerivative · entry 1

D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,729

F1 · price: The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2022 through December 30, 2022. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.

SEC source: 0001285550-22-000069 · wf-form4_166551295326851.xml · nonDerivative · entry 1

SABRA MAZIN · CIK 0001947604 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,900

F1 · shares: The shares are restricted stock and vest as follows: (i) one-third (1/3rd) on the first anniversary of the grant date; (ii) one-third (1/3rd) on the second anniversary of the grant date; and (iii) one-third (1/3rd) on the third anniversary of the grant date.

SEC source: 0001285550-22-000064 · wf-form4_166492186503764.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,639

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $10.19 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending September 30, 2022.

SEC source: 0001285550-22-000063 · wf-form4_166492184686141.xml · nonDerivative · entry 1

FLETCHER R JOHN · CIK 0001215024 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,286

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $10.19 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending September 30, 2022.

SEC source: 0001285550-22-000062 · wf-form4_166492182952022.xml · nonDerivative · entry 1

Girin Pascal E R · CIK 0001329811 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,752

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $10.19 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending September 30, 2022.

SEC source: 0001285550-22-000061 · wf-form4_166492181090364.xml · nonDerivative · entry 1

JOHNSON B KRISTINE · CIK 0001231984 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,022

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $10.19 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending September 30, 2022.

SEC source: 0001285550-22-000056 · wf-form4_166481726876489.xml · nonDerivative · entry 1

D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,477

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001285550-22-000050 · wf-form4_166129276607234.xml · nonDerivative · entry 1

STIGALL L. JEREMY · CIK 0001929859 · GM, Biologics & Drug Delivery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,692

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

F2 · balance_after: Includes 1,369 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan.

SEC source: 0001285550-22-000051 · wf-form4_166129278397329.xml · nonDerivative · entry 1

BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,638

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001285550-22-000049 · wf-form4_166129274313574.xml · nonDerivative · entry 1

D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,435

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

F2 · balance_after: Includes 804 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan.

SEC source: 0001285550-22-000045 · wf-form4_166068282013601.xml · nonDerivative · entry 2

BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,095

F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0001285550-22-000045 · wf-form4_166068282013601.xml · nonDerivative · entry 1

BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,962

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

F2 · balance_after: Includes 2,155 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan.

SEC source: 0001285550-22-000036 · wf-form4_165766703828158.xml · nonDerivative · entry 1

BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,585

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001285550-22-000034 · wf-form4_165732008175132.xml · nonDerivative · entry 1

STIGALL L. JEREMY · CIK 0001929859 · GM, Biologics & Drug Delivery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,526

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001285550-22-000032 · wf-form4_165713269383762.xml · nonDerivative · entry 1

JOHNSON B KRISTINE · CIK 0001231984 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,685

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $12.63 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending June 30, 2022.

SEC source: 0001285550-22-000031 · wf-form4_165713267692568.xml · nonDerivative · entry 1

FLETCHER R JOHN · CIK 0001215024 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,584

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $12.63 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending June 30, 2022.

SEC source: 0001285550-22-000030 · wf-form4_165713266139806.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,545

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $12.63 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending June 30, 2022.

SEC source: 0001285550-22-000029 · wf-form4_165713264416431.xml · nonDerivative · entry 1

Girin Pascal E R · CIK 0001329811 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,047

F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $12.63 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending June 30, 2022.

SEC source: 0001285550-22-000024 · wf-form4_165523772954876.xml · derivative · entry 2

STIGALL L. JEREMY · CIK 0001929859 · GM, Biologics & Drug Delivery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,685

Underlying: Common Stock · 11,685 shares

Expires 2032-06-10

F2 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

SEC source: 0001285550-22-000024 · wf-form4_165523772954876.xml · nonDerivative · entry 1

STIGALL L. JEREMY · CIK 0001929859 · GM, Biologics & Drug Delivery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,211

F1 · shares: The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

SEC source: 0001285550-22-000023 · wf-form4_165523769683678.xml · derivative · entry 2

BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,742

Underlying: Common Stock · 46,742 shares

Expires 2032-06-10

F3 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

SEC source: 0001285550-22-000023 · wf-form4_165523769683678.xml · nonDerivative · entry 1

BURNETT JOSEPH MICHAEL · CIK 0001721010 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,249

F1 · shares: The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

F2 · balance_after: Includes 1,349 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan.

SEC source: 0001285550-22-000022 · wf-form4_165523765989689.xml · derivative · entry 2

D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,600

Underlying: Common Stock · 15,600 shares

Expires 2032-06-10

F3 · derivative.exercise_date: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

SEC source: 0001285550-22-000022 · wf-form4_165523765989689.xml · nonDerivative · entry 1

D'Alessandro Danilo · CIK 0001825163 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,214

F1 · shares: The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

F2 · balance_after: Includes 1,349 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan.

SEC source: 0001420506-22-001135 · doc4_1012.xml · derivative · entry 2

Klein Matthew B. · CIK 0001808968 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,179

Underlying: Common Stock · 6,179 shares

Expires 2032-05-25

F2 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001135 · doc4_1012.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,272

F1 · price: The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001145 · doc4_1008.xml · derivative · entry 2

FLETCHER R JOHN · CIK 0001215024 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,179

Underlying: Common Stock · 6,179 shares

Expires 2032-05-25

F2 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001145 · doc4_1008.xml · nonDerivative · entry 1

FLETCHER R JOHN · CIK 0001215024 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,211

F1 · price: The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001143 · doc4_1010.xml · derivative · entry 2

JOHNSON B KRISTINE · CIK 0001231984 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,179

Underlying: Common Stock · 6,179 shares

Expires 2032-05-25

F2 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001143 · doc4_1010.xml · nonDerivative · entry 1

JOHNSON B KRISTINE · CIK 0001231984 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,413

F1 · price: The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001140 · doc4_1013.xml · derivative · entry 2

LIAU LINDA M. · CIK 0001890712 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,179

Underlying: Common Stock · 6,179 shares

Expires 2032-05-25

F2 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001140 · doc4_1013.xml · nonDerivative · entry 1

LIAU LINDA M. · CIK 0001890712 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,695

F1 · price: The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders

SEC source: 0001420506-22-001139 · doc4_1009.xml · derivative · entry 2

Girin Pascal E R · CIK 0001329811 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,179

Underlying: Common Stock · 6,179 shares

Expires 2032-05-25

F2 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001139 · doc4_1009.xml · nonDerivative · entry 1

Girin Pascal E R · CIK 0001329811 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,379

F1 · price: The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001136 · doc4_1014.xml · derivative · entry 2

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,179

Underlying: Common Stock · 6,179 shares

Expires 2032-05-25

F2 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001136 · doc4_1014.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,662

F1 · price: The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001131 · doc4_1007.xml · derivative · entry 2

FALLON LYNNETTE C · CIK 0001195654 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,179

Underlying: Common Stock · 6,179 shares

Expires 2032-05-25

F2 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001420506-22-001131 · doc4_1007.xml · nonDerivative · entry 1

FALLON LYNNETTE C · CIK 0001195654 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,855

F1 · price: The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders.

SEC source: 0001171520-22-000239 · eps10158.xml · nonDerivative · entry 1

Richards Timothy T. · CIK 0001601831 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,393

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $9.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2022.

SEC source: 0001171520-22-000237 · eps10157.xml · nonDerivative · entry 1

Girin Pascal E R · CIK 0001329811 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,110

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $9.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2022.

SEC source: 0001171520-22-000235 · eps10156.xml · nonDerivative · entry 1

JOHNSON B KRISTINE · CIK 0001231984 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,144

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $9.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2022.

SEC source: 0001171520-22-000233 · eps10159.xml · nonDerivative · entry 1

FLETCHER R JOHN · CIK 0001215024 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,942

F1 · price: These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $9.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2022.